Featured News

3

UC, Nexigen agree to collaborate on AI security

April 23, 2024

An agreement between the University of Cincinnati and information technology and cybersecurity firm Nexigen will lead to collaboration on artificial intelligence, which includes a goal of making the technology more secure. Nexigen, one of the Cincinnati region's largest IT service and cybersecurity firms, builds technology solutions for companies in the United States. While not a legally binding contract, the agreement between the Kentucky-based company and UC will lead to cooperation on securing grants, give UC students real-world experience and provide Nexigen with expertise from UC faculty and students.

Debug Query for this

Latest News

3

UC, Nexigen agree to collaborate on AI security

April 23, 2024

An agreement between the University of Cincinnati and information technology and cybersecurity firm Nexigen will lead to collaboration on artificial intelligence, which includes a goal of making the technology more secure. Nexigen, one of the Cincinnati region's largest IT service and cybersecurity firms, builds technology solutions for companies in the United States. While not a legally binding contract, the agreement between the Kentucky-based company and UC will lead to cooperation on securing grants, give UC students real-world experience and provide Nexigen with expertise from UC faculty and students.

5

Cancer Center hosting event to kick off Ride Cincinnati 2024...

Event: May 3, 2024 12:00 PM

The University of Cincinnati Cancer Center is hosting a special kickoff event on Friday, May 3 from 12-1 p.m. in Kresge Auditorium to celebrate the opening of registration for Ride Cincinnati 2024, an annual fundraiser for local cancer research.

11

Tornado's effects linger 25 years later

April 9, 2024

Biologists at the University of Cincinnati documented the recovery of a forest decimated by a tornado 25 years ago. Their findings demonstrate how major disturbances can have lasting and unexpected consequences for biodiversity.

13

Pulmonary arterial hypertension drug studied at UC receives FDA...

April 4, 2024

Clinical research conducted at the University of Cincinnati College of Medicine and UC Health played a role in the U.S. Food and Drug Administration's March 26 approval of WINREVAIRâ„¢ (sotatercept-csrk) for the treatment of pulmonary arterial hypertension (PAH) in adults.

15

The world is driven by liquid-vapor phase change

April 4, 2024

University of Cincinnati professor Kishan Bellur is captivated by evaporation - a phenomena that is happening all the time, all around us, but few of us notice. Most liquid surfaces, for example, water in a test tube, are not flat. There is a slight curvature to it called the meniscus. As the liquid evaporates, it climbs up the side of the tube forming a very thin liquid film that is hard to see with the naked eye. Understanding the evaporation process and the behavior of these films are the focus of Bellur's latest research.

Load More
Debug Query for this